Jesús
Pérez Sánchez-Toledo
Profesor Titular de Universidad
King's College London
Londres, Reino UnidoPublications in collaboration with researchers from King's College London (43)
2024
-
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
Schizophrenia bulletin, Vol. 50, Núm. 3, pp. 496-512
-
Cognitive remediation therapy to enhance cognition and improve recovery in early psychosis: the ECLIPSE research programme including an RCT
Programme Grants for Applied Research, Vol. 12, Núm. 4
-
Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS
Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272
-
Effects of cannabidiol on symptoms in people at clinical high risk for psychosis
World Psychiatry
-
Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol
Psychological Medicine, Vol. 54, Núm. 5, pp. 993-1003
-
Understanding the Mechanisms of Cognitive Remediation on Recovery in People With Early Psychosis: A Mediation and Moderation Analysis
Schizophrenia bulletin, Vol. 50, Núm. 6, pp. 1371-1381
2023
-
Cognitive Remediation Works But How Should We Provide It? An Adaptive Randomized Controlled Trial of Delivery Methods Using a Patient Nominated Recovery Outcome in First-Episode Participants
Schizophrenia bulletin, Vol. 49, Núm. 3, pp. 614-625
-
Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk
Schizophrenia Bulletin Open, Vol. 4, Núm. 1
-
Satisfaction with cognitive remediation therapy: its effects on implementation and outcomes using the cognitive remediation satisfaction scale
Schizophrenia, Vol. 9, Núm. 1
-
What interventions should we implement in England's mental health services? The mental health implementation network (MHIN) mixed-methods approach to rapid prioritisation
Frontiers in Health Services, Vol. 3
2022
-
Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report
European Archives of Psychiatry and Clinical Neuroscience, Vol. 272, Núm. 3, pp. 461-475
-
Determinants of patient-reported outcome trajectories and symptomatic recovery in Improving Access to Psychological Therapies (IAPT) services
Psychological Medicine, Vol. 52, Núm. 14, pp. 3231-3240
-
The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis
Schizophrenia Bulletin Open, Vol. 3, Núm. 1
-
Treating common mental disorder including psychotic experiences in the primary care improving access to psychological therapies programme (the TYPPEX study): protocol for a stepped wedge cluster randomised controlled trial with nested economic and process evaluation of a training package for therapists
BMJ open, Vol. 12, Núm. 6, pp. e056355
2021
-
Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function
Translational Psychiatry, Vol. 11, Núm. 1
-
Correction: Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function (Translational Psychiatry, (2021), 11, 1, (579), 10.1038/s41398-021-01705-z)
Translational Psychiatry
-
Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit
Schizophrenia Research, Vol. 227, pp. 10-17
-
Development and external validation of the Psychosis Metabolic Risk Calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosis
The Lancet Psychiatry, Vol. 8, Núm. 7, pp. 589-598
-
Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosis
Human Brain Mapping, Vol. 42, Núm. 2, pp. 439-451
-
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes
Neuropsychopharmacology, Vol. 46, Núm. 8, pp. 1468-1474